Burning Rock Biotech Limited (BNR)
USD 2.79
(-2.79%)
USD 2.79
(-2.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 537.43 Million CNY | -4.58% |
| 2022 | 563.23 Million CNY | 10.9% |
| 2021 | 507.86 Million CNY | 18.13% |
| 2020 | 429.9 Million CNY | 12.64% |
| 2019 | 381.67 Million CNY | 82.74% |
| 2018 | 208.86 Million CNY | 87.89% |
| 2017 | 111.16 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 125.62 Million CNY | 3.75% |
| 2024 Q2 | 135.53 Million CNY | 7.89% |
| 2023 Q3 | 127.56 Million CNY | -12.79% |
| 2023 Q1 | 142.51 Million CNY | 0.2% |
| 2023 Q2 | 146.26 Million CNY | 2.63% |
| 2023 FY | 537.43 Million CNY | -4.58% |
| 2023 Q4 | 121.08 Million CNY | -5.08% |
| 2022 Q4 | 142.23 Million CNY | -8.02% |
| 2022 Q3 | 154.63 Million CNY | 18.18% |
| 2022 Q2 | 130.84 Million CNY | -3.45% |
| 2022 FY | 563.23 Million CNY | 10.9% |
| 2022 Q1 | 135.52 Million CNY | -8.02% |
| 2021 FY | 507.86 Million CNY | 18.13% |
| 2021 Q4 | 147.34 Million CNY | 16.37% |
| 2021 Q3 | 126.61 Million CNY | -0.52% |
| 2021 Q2 | 127.27 Million CNY | 19.37% |
| 2021 Q1 | 106.62 Million CNY | -19.05% |
| 2020 Q2 | 106.97 Million CNY | 58.88% |
| 2020 FY | 429.9 Million CNY | 12.64% |
| 2020 Q1 | 67.32 Million CNY | -24.07% |
| 2020 Q4 | 131.72 Million CNY | 6.33% |
| 2020 Q3 | 123.88 Million CNY | 15.81% |
| 2019 Q2 | 84.81 Million CNY | -18.81% |
| 2019 Q4 | 88.67 Million CNY | -14.51% |
| 2019 Q3 | 103.72 Million CNY | 22.3% |
| 2019 Q1 | 104.46 Million CNY | 60.04% |
| 2019 FY | 381.67 Million CNY | 82.74% |
| 2018 FY | 208.86 Million CNY | 87.89% |
| 2018 Q4 | 65.27 Million CNY | 0.0% |
| 2017 FY | 111.16 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -1619.847% |
| Biodesix, Inc. | 49.08 Million USD | -994.862% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -21121.529% |
| Castle Biosciences, Inc. | 219.78 Million USD | -144.524% |
| DarioHealth Corp. | 20.35 Million USD | -2540.699% |
| Exact Sciences Corporation | 2.49 Billion USD | 78.501% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 85.32% |
| Illumina, Inc. | 4.5 Billion USD | 88.068% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -17170.978% |
| iSpecimen Inc. | 9.92 Million USD | -5313.226% |
| Standard BioTools Inc. | 106.34 Million USD | -405.393% |
| 23andMe Holding Co. | 219.63 Million USD | -144.691% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 71.502% |
| NeoGenomics, Inc. | 591.64 Million USD | 9.162% |
| Inotiv, Inc. | 572.42 Million USD | 6.113% |
| Psychemedics Corporation | 22.09 Million USD | -2332.053% |
| Prenetics Global Limited | 21.74 Million USD | -2371.798% |
| Precipio, Inc. | 15.19 Million USD | -3436.455% |
| RadNet, Inc. | 1.61 Billion USD | 66.756% |
| Sotera Health Company | 1.04 Billion USD | 48.781% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -1073.823% |
| Exagen Inc. | 52.54 Million USD | -922.751% |
| Natera, Inc. | 1.08 Billion USD | 50.356% |
| Aspira Women's Health Inc. | 9.15 Million USD | -5771.04% |
| Neogen Corporation | 924.22 Million USD | 41.85% |
| Myriad Genetics, Inc. | 678.4 Million USD | 20.779% |
| ICON Public Limited Company | 8.12 Billion USD | 93.381% |
| Bionano Genomics, Inc. | 36.11 Million USD | -1388.08% |
| CareDx, Inc | 280.32 Million USD | -91.719% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 312.97 Million USD | -71.719% |
| Guardant Health, Inc. | 563.94 Million USD | 4.701% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -5400.416% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -85.827% |
| Sera Prognostics, Inc. | 306 Thousand USD | -175532.353% |
| OPKO Health, Inc. | 863.49 Million USD | 37.76% |
| Personalis, Inc. | 73.48 Million USD | -631.393% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -3920.477% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -1073.823% |
| MDxHealth SA | 70.19 Million USD | -665.653% |
| Prenetics Global Limited | 21.74 Million USD | -2371.798% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -59916.483% |
| Trinity Biotech plc | 56.83 Million USD | -845.656% |
| Neuronetics, Inc. | 71.34 Million USD | -653.259% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -21121.529% |